Navigation Links
New Report Distorts Truth About Pesticides
Date:8/1/2008

WASHINGTON, Aug. 1 /PRNewswire/ -- A report released yesterday by the Center for Public Integrity, "Perils of the New Pesticides," distorts the truth about the health effects of chemicals in pest management products, according to the Consumer Specialty Products Association (CSPA). Of specific concern is the author's misinterpretation of data collected by the U.S. Environmental Protection Agency's incident reporting system related to pyrethrins, natural insecticides produced by certain species of the chrysanthemum plant, and its synthetic counterparts, pyrethroids. By improperly using EPA data and drawing faulty conclusions from it, the report has needlessly caused alarm about both ingredients which have been used in pesticide products for decades.

CSPA points out that EPA's incidence data base can be a useful indicator of the consumer experience with products only to the extent that the data have been carefully evaluated and considered in the context of the limitations of the incident reporting system and with regard to extensive use of the products being studied. CPI took a simplistic approach that failed in this regard.

CSPA further notes that the data includes every type of case represented in raw data form, such as misuse, abuse, and exposures resulting from attempts at self harm such as suicides. No incident is required to undergo investigation, confirmation or validation before being added to the EPA's raw dataset.

"The basic premise behind the author's paper -- that incident data in its raw form is signaling a serious health threat by these ingredients -- is fundamentally flawed," said Chris Cathcart, CSPA President. "There was no evaluation by expert clinical and medical toxicologists to sort out incidents that, under further scrutiny by EPA's team of expert toxicologists and medical professionals, would have been excluded from the raw data set to allow for a meaningful analysis."

In the spirit of cooperation, CSPA facilitated more than ten hours of interview time with nationally recognized scientific and medical experts in the area of pyrethrins, pyrethroids and incidence reporting with the Center for Public Integrity. One of these experts has been involved with the EPA's reporting structure for incident data since its inception. That expert cautioned the author against drawing conclusions from the dataset that simply could not be supported from a scientific and medical basis given its inherent limitations.

"Clearly, the CPI chose not to invest the time and energy necessary to conduct a thorough analysis, and the result is a seriously flawed report that merely serves to spread misinformation about products that have served consumers well for decades," said Cathcart. "Because of their superior safety profile, pyrethrins and pyrethroids have been the replacement ingredients of choice following the removal of chlorpyrifos and other organophosphates from the marketplace. Pyrethrins and pyrethroids have helped to provide public health benefits by controlling pests that can transmit to humans diseases such as Lyme disease and West Nile virus."

About CSPA

The Consumer Specialty Products Association is a non-profit national trade association representing approximately 250 companies engaged in the manufacture, formulation, distribution and sale of hundreds of familiar consumer products. It is organized into seven divisions: Aerosol Products, Air Care, Antimicrobial Products, Cleaning Products, Pest Management Products, Industrial and Automotive Specialty Chemicals, and Polishes and Floor Maintenance. For more information, please visit http://www.cspa.org.


'/>"/>
SOURCE Consumer Specialty Products Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Virginia Tech Report Has National Importance
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
4. Haemacure Reports Third Quarter 2007 Results
5. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
6. Biotech Finishes on a High in August, Burrill Report Says
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. First New York/New Jersey Health Care Report Card Released
11. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, Inc. ... will take whatever measures required to build a strong ... which is currently listed on the OTC Markets-pink current ... Chairman and CEO, "We are seeing an anomaly in ... understand, not only by the Company, but shareholders and ...
(Date:6/24/2016)... 2016  Consumers have taken a more active ... more emphasis on patient outcomes. ... the pharmaceutical industry have evolved beyond just providing ... are focusing on becoming more patient-oriented across their ... services that improve health. ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
Breaking Medicine Technology: